Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Machine learning can help predict the life expectancy of heart failure patients, according to new research published in the European Journal of Heart Failure.
AI can identify patients at risk of dying—of any cause—within the next year or of developing an irregular heartbeat, according to two new studies to be presented at the American Heart Association’s Scientific Sessions 2019.
RSNA 2019, the world’s largest radiology conference, kicks off at Chicago’s McCormick Place on Sunday, Dec. 1. This year's show promises to include more AI content than ever before.
Medical students see AI technologies as a considerable threat to the future of radiology, according to a new study published in the European Journal of Radiology.
Working closely with AI has led researchers from one institution to embrace a familiar piece of technology that may surprise many of their peers: the USB drive.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.